APA (7th ed.) Citation

Eman Abdelhakeem, Mohamed El-Nabarawi, & Rehab Shamma. (2021). Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: In-vitro optimization and ex-vivo assessment. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Eman Abdelhakeem, Mohamed El-Nabarawi, and Rehab Shamma. Lipid-based Nano-formulation Platform for Eplerenone Oral Delivery as a Potential Treatment of Chronic Central Serous Chorioretinopathy: In-vitro Optimization and Ex-vivo Assessment. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Eman Abdelhakeem, et al. Lipid-based Nano-formulation Platform for Eplerenone Oral Delivery as a Potential Treatment of Chronic Central Serous Chorioretinopathy: In-vitro Optimization and Ex-vivo Assessment. Taylor & Francis Group, 2021.